Doctors are positive about the SGLT-2 inhibitor…“Yet, it lacks in patient cases”

The treatment industry for ‘diabetes’, considered as one of the chronic diseases, has begun a new changing era. So far, the existing diabetes treatments have had side effects of weight increases and hypoglycemia.

However, as the ‘SGLT-2 inhibitor’ has been launched along with the ‘DPP-4 inhibitor’ showing the new pharmacological mechanism to increase blood sugar, doctors now have more options ...